Reticulum cell sarcoma (RCS) is a rare nonHodgkin's large cell lymphoma which can masquerade as chronic uveitis. This disease occurs in two broad forms, with one variety primarily involving the systemic lymph nodes, visceral organs, and uveal tract and another primarily affecting the retina, vitreous, and central nervous system (CNS). In the Rappaport classification the disease was relabelled as a histiocytic lymphoma.' More recently surface marker studies2 have shown these cells to be of lymphoid and not histiocytic origin.
Over 100 cases"'0 of ocular RCS have been described in the literature. Typically, the patients have been in their sixth or seventh decade when either a unilateral or bilateral painless decrease in visual acuity occurred. No sexual or racial predilection has been noted. Invariably, ocular findings include vitreous cells and debris (Fig. 1) . The retina and choroid ( Fig. 2) , the conjunctiva, and the optic nerve may be infiltrated by tumour. Less commonly an anterior chamber reaction or an exudative retinal detachment may be presenting sign (Fig. 3) . Systemic spread is common, with the CNS being affected first (Fig. 4) 
Results
The age at presentation ranged from 27 to 77 years, mean 65. Nine out of 14 or 64% of the patients were women, with no black patients in our series. Disease was bilateral in 71% of the patients. There was vitritis in 100% of the patients and retinal/subretinal lesions in 50%. Three of the fourteen patients had an anterior uveitis as well, with one being moderately intense.
Initial investigations included a complete systemic evaluation with head CT scan, lumbar puncture for examination of cerebrospinal fluid, and bone marrow aspiration. Central nervous system involvement was present at the time of initial diagnosis in two cases and subsequently developed in four additional patients. All patients with CNS lesions except one died about six months after the presence of these lesions was confirmed.
The diagnosis of RCS was confirmed in 11 patients by means of a vitreous aspiration. This was performed with a 19 gauge needle introduced via the pars plana with 0.5 ml of fluid aspirated. One patient refused any diagnostic or therapeutic manoeuvres and two patients were not suspected of harbouring RCS until the time of necropsy. Nine patients who were diagnosed by vitreous aspiration underwent radiation therapy. Of the two patients who received radiation only to the orbits and not the brain one subsequently developed CNS lesions. One patient who received CNS and orbital radiation had an ocular recurrence after one year and systemic recurrence 18 months after initial diagnosis (Fig. 4) but was without evidence of CNS spread. In an additional patient an ocular recurrence and a new brain lesion appeared one and one-half years after ocular and CNS radiation.
In patients who received primary radiation therapy, chemotherapy was reserved for recurrent CNS disease and was effective in one case in causing regression of tumour and preventing death. Two patients received intravenous cytosine arabinoside (Ara-C) as primary therapy for localised ocular disease. At three months follow-up there was no evidence of metastatic disease and partial improvement in ocular findings, though visual acuity remained unchanged.
Our chemotherapy protocol was to give Ara-C 2000-3000 mg/m2 intravenously over a period of one hour. Treatment was repeated every 12 hours for three doses in the hospital and then as single doses repeated at weekly intervals as an outpatient. Toxicity was minimal, consisting of nausea, vomiting, and myelosuppression. No patients showed signs of CNS or cerebellar toxicity.
Discussion
Our findings confirm many of those noted in smaller series of cases of RCS. Although the mean age of 65 in our series is similar to that in previous reports, one patient was 27 at initial diagnosis. Interestingly, the first patient described with RCS was also 27" and so emphasises that, though very unusual, this condition should be thought of in younger patients as well as the elderly.
The most frequent finding in this series was an unexplained posterior and occasionally anterior uveitis. While negative blood studies, chest x-ray, and a thorough retinal examination can help to exclude some causes of uveitis, a vitreous aspiration is required for definitive diagnosis. This procedure was performed in all of our patients who consented and in whom the diagnosis was suspected. When present, a characteristic funduscopic picture of multicentric subretinal pigment epithelial lesions'2'3 can help suggest the diagnosis of RCS and was present in half our cases.
Tissue typing is useful in systemic lymphomas both for prognosis and in guiding therapy. Determining whether our cases of RCS were of B-cell or T-cell origin was very difficult given the small volume of vitreous aspirate obtained in individual cases. Only one patient could be typed and this patient had a Tcell lymphoma. Other workers have noted a predominance of B-cell lymphomas,'4 but all involve a small number of cases. Whether this information will become useful in future in planning treatment of RCS remains to be determined. It is possible that a pars plana vitrectomy would facilitate typing by providing 16 The use of chemotherapy for RCS is less clear. The experience of Char et al. 17 with three patients given combination chemotherapy, including intrathecal treatment, was favourable. Baumann et al. 8 successfully treated one patient with intravenous high-dose cytosine arabinoside (Ara-C) who suffered recurrence after radiation therapy. Evidence suggests that Ara-C reaches therapeutic levels in the CSF and vitreous after intravenous therapy.'8 Our experience with three patients given high-dose intravenous Ara-C has been encouraging. Our one patient with the best response had received radiation therapy primarily. A prospective trial to evaluate the role of systemic high-dose Ara-C in combination with ocular and CNS irradiation as primary therapy needs to be undertaken.
In summary, a high degree of suspicion is needed in patients in whom a chronic posterior uveitis of obscure aetiology persists. Chronic uveitis is unusual in people over 60, and the differential diagnosis includes sarcoidosis, syphilis, tuberculosis, toxoplasmosis, Whipple's disease, cytomegalovirus infection, metastatic disease, and amyloid disease. 
